| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 07/11/2002 | WO2002053581A2 Spliceosome mediated rna trans-splicing |
| 07/11/2002 | WO2002053576A1 Viral delivery system for infectious transfer of large genomic dna inserts |
| 07/11/2002 | WO2002053193A2 Tissue engineering of three-dimensional vascularized using microfabricated polymer assembly technology |
| 07/11/2002 | WO2002053191A1 Compositions for gene therapy of rheumatoid arthritis including a gene encoding an anti-angiogenic protein or parts thereof |
| 07/11/2002 | WO2002053185A2 Anti-inflammatory use of polycationic compounds |
| 07/11/2002 | WO2002053181A1 Enterohemorragic escherichia coli vaccine |
| 07/11/2002 | WO2002053177A2 Agents and methods for treating pain |
| 07/11/2002 | WO2002053163A1 Medicines for relieving intestinal disorders |
| 07/11/2002 | WO2002053110A2 Pharmaceutical preparation for douches and/or irrigations of natural or pathological cavities in the human body |
| 07/11/2002 | WO2002053017A2 Compositions and methods for the therapy, diagnosis and monitoring of breast cancer |
| 07/11/2002 | WO2002052955A1 Nutritional and therapeutical preparations having antioxidant activity |
| 07/11/2002 | WO2002052934A2 Pesticidal and antiparasitic compositions |
| 07/11/2002 | WO2002022787A3 Differential treatment of selected parts of a single cell with different fluid components |
| 07/11/2002 | WO2002020724A3 Adenoviral targeting and manipulation of immune system response using targeting peptides |
| 07/11/2002 | WO2002014511A3 Regulation of human p2y1-like g protein-coupled receptor |
| 07/11/2002 | WO2002014479B1 Isolated mammalian neural stem cells, methods of making such cells, and methods of using such cells |
| 07/11/2002 | WO2001091783A3 Methods and compositions for producing a neurosalutary effect in a subject |
| 07/11/2002 | WO2001079445A3 Pluripotent cells comprising allogenic nucleus and mitochondria |
| 07/11/2002 | WO2001013927A9 Improved topical compositions containing probiotic bacteria, spores, and extracellular products and uses thereof |
| 07/11/2002 | WO2000066179A9 Noninvasive genetic immunization, expression products therefrom, and uses thereof |
| 07/11/2002 | WO2000064488A9 Somatic transgene immunization and related methods |
| 07/11/2002 | WO2000052187A9 Enhanced system for construction of adenovirus vectors |
| 07/11/2002 | US20020091448 Tissue engineered testicular prosthesis and use thereof |
| 07/11/2002 | US20020091246 Dendritic cell co-stimulatory molecules |
| 07/11/2002 | US20020091244 Nucleotide sequences for use in diagnosis and treatment of cancer and immunological disorders |
| 07/11/2002 | US20020091229 Photopolymerizable biodegradable hydrogels as tissue contacting materials and controlled-release carriers |
| 07/11/2002 | US20020091098 Also administering to the subject an effective amount of an mda-7 protein. |
| 07/11/2002 | US20020090725 Collagen; for use in forming tissues and organs |
| 07/11/2002 | US20020090724 Activation of regulatory T cells by alpha-melanocyte stimulating hormone |
| 07/11/2002 | US20020090723 Generating preferential cell cultures; isolate blastocyst, culture, recover cells |
| 07/11/2002 | US20020090719 Expression vectors containing hybrid ubiquitin promoters |
| 07/11/2002 | US20020090715 Method for the preparation of a viral vector by inter-molecular homologous recombination |
| 07/11/2002 | US20020090603 Methods of differentiating and protecting cells by modulating the P38/MEF2 pathway |
| 07/11/2002 | US20020090419 Food formulations with a high calcium content |
| 07/11/2002 | US20020090400 Washing egg shells with purified water while stirring, autoclaving egg shells; drying and crushing to desired grain size |
| 07/11/2002 | US20020090399 Cytoprotective biocompatible containment systems for biologically active materials and methods of making same |
| 07/11/2002 | US20020090370 Novel porcine protein and uses thereof |
| 07/11/2002 | US20020090365 For therapy of vaginal and gastrointestinal infections |
| 07/11/2002 | US20020090364 Cells designed as traps and their use as medicines |
| 07/11/2002 | US20020090362 Immunotherapy using cytotoxic t lymphocytes (ctl) |
| 07/11/2002 | US20020090360 Inflammatory cytokine secretion inhibition |
| 07/11/2002 | US20020090359 Transforming growth factor regulation |
| 07/11/2002 | US20020090358 Chronic lymphocytic leukemia treatment |
| 07/11/2002 | US20020090357 Contacting a naive T cell with a stimulatory signal and an appropriate amount of a combination of Vitamin D3 and Dexamethasone, wherein contacting results in differentiation to a regulatory T cell |
| 07/11/2002 | DE10064732A1 Enterale Zubereitung zur Stärkung des Immunsystems Enteral preparation for strengthening the immune system |
| 07/11/2002 | CA2467434A1 Reversible mhc multimer staining for functional purification of antigen-specific t cells |
| 07/11/2002 | CA2434118A1 Spliceosome mediated rna trans-splicing |
| 07/11/2002 | CA2433552A1 Pharmaceutical preparation for douches and/or irrigations of natural or pathological cavities in the human body |
| 07/11/2002 | CA2433332A1 Agents and methods for treating pain |
| 07/11/2002 | CA2433225A1 Isolated molecules comprising epitopes containing sulfated moieties, antibodies to such epitopes, and uses thereof |
| 07/10/2002 | EP1221490A2 Recombinant adenoviral vectors and their utilization in the treatment of various types of hepatic, renal and pulmonary fibrosis and hypertrophic scars |
| 07/10/2002 | EP1221477A2 Transfection of vertebrate cells e.g. by homologous recombination |
| 07/10/2002 | EP1220938A1 Materials and methods for simplified aav production |
| 07/10/2002 | EP1220929A1 Human ubiquitin protease |
| 07/10/2002 | EP1220925A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 07/10/2002 | EP1220922A2 Treatment of chronic inflammatory disease by inhibiting sub-groups of activated t-cells |
| 07/10/2002 | EP1220917A1 P-glycoproteins from macaca fascicularis and uses thereof |
| 07/10/2002 | EP1220913A1 G protein-coupled receptor up-regulated in prostate cancer and uses thereof |
| 07/10/2002 | EP1220900A2 Gene transfer vectors for treating autoimmune diseases and diseases with immunopathogenesis by therapy |
| 07/10/2002 | EP1220868A1 Extracorporeal endotoxin removal method |
| 07/10/2002 | EP1220688A1 Treatment of dermal tumors, warts, and viral infections using heat-killed p. acnes |
| 07/10/2002 | EP1220684A2 Methods related to immunostimulatory nucleic acid-induced interferon |
| 07/10/2002 | EP1220681A2 Opaminergic neuronal survival-promoting factors and uses thereof |
| 07/10/2002 | EP1220679A1 Cell-based gene therapy for the pulmonary system |
| 07/10/2002 | EP1220611A1 Suppressor cells for prevention and treatment of immune responses in transplantation |
| 07/10/2002 | EP0934427A4 Rh blood group antigen compositions and methods of use |
| 07/10/2002 | CN2499033Y Natural periostracum cicada finishing tool |
| 07/10/2002 | CN1357618A Biological bacteriophagic Bdellovibrio prepn and its production process |
| 07/10/2002 | CN1357373A Oral capsule for treating condyloma acuminata |
| 07/10/2002 | CN1357369A Externally applied ointment for treating burns, wound and frost bite and its prepn |
| 07/10/2002 | CN1357367A Medicine powder for treating epilepsy radically and its prepn |
| 07/10/2002 | CN1357364A Chinese medicine for treating bradyrhythmia caused by hypotension |
| 07/10/2002 | CN1357362A Stone-eliminating Jinyin medicine powder |
| 07/10/2002 | CN1357358A Blood circulation activating and pain stopping ointment for treating bone injury and its prepn process |
| 07/10/2002 | CN1357356A Fracture setting granule for treating bone injury and its prepn process |
| 07/10/2002 | CN1357355A Fracture setting Chinese medicine capsule for treating bone injury and its prepn process |
| 07/10/2002 | CN1357349A Virus eliminating medicine |
| 07/10/2002 | CN1357347A Chinese medicine with physique enhancing and disease treating functions |
| 07/10/2002 | CN1357344A Nephrosis treating medicine and its prepn |
| 07/10/2002 | CN1357342A Nephrolithiasis treating medicine |
| 07/10/2002 | CN1357340A Snake blood prepn for treating hemopathy |
| 07/10/2002 | CN1357337A Prepn of Xianjia medicine granule for treating hyperprolactin |
| 07/10/2002 | CN1357334A Artificial bear bile powder |
| 07/10/2002 | CN1357310A Soluble pearl powder compound |
| 07/10/2002 | CN1087173C Medicine for treating liver cancer and preparing process thereof |
| 07/09/2002 | US6417227 Methods of delivery of cetyl myristoleate |
| 07/09/2002 | US6417163 Compositions and methods for controlling plant pests |
| 07/09/2002 | US6416999 Cell differentiation |
| 07/09/2002 | US6416998 Polypeptides |
| 07/09/2002 | US6416975 Human glycine transporter type 2 |
| 07/09/2002 | US6416765 Botulinum toxin injected into the pancreas |
| 07/09/2002 | US6415992 Spray device containing nitrogen-carbon dioxide propellent gas mixture |
| 07/09/2002 | CA2233170C Lactose-containing food composition for infants |
| 07/04/2002 | WO2002052004A1 Gene involved in apoptosis regulation |
| 07/04/2002 | WO2002051994A2 Polypeptides |
| 07/04/2002 | WO2002051988A2 Thymic epithelial progenitor cells and uses thereof |
| 07/04/2002 | WO2002051987A1 System for the cell-specific and development-specific selection of differentiating embryonic stem cells, adult stem cells and embryonic germline cells |
| 07/04/2002 | WO2002051986A2 Educated nk t cells and their uses in the treatment of immune-related disorders |
| 07/04/2002 | WO2002051981A2 Defects in periaxin associated with myelinopathies |
| 07/04/2002 | WO2002051443A2 Aqueous gel comprising a gelling agent such as kappa carrageenan and at least 85 % water |